Inmune Bio's total assets for Q1 2026 were $25.82M, a decrease of -20.19% from the previous quarter. INMB total liabilities were $6.19M for the fiscal quarter, a -29.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.